<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Infographic: Statistical Modeling in Clinical Trials</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <script src="https://cdn.jsdelivr.net/npm/chart.js"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700;900&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Inter', sans-serif;
            background-color: #111827; 
        }
        .chart-container {
            position: relative;
            margin: auto;
            height: 320px;
            width: 100%;
            max-width: 500px;
        }
        @media (min-width: 768px) {
            .chart-container {
                height: 384px;
            }
        }
        .stat-card h3 {
            color: #007BFF;
        }
        .flow-line {
            width: 2px;
            background-color: #6B7280;
            margin-left: auto;
            margin-right: auto;
        }
        .flow-node {
            border-color: #007BFF;
        }
        .forest-plot-line {
            position: absolute;
            height: 100%;
            width: 2px;
            background-color: #DC3545;
            left: 50%;
            transform: translateX(-50%);
            z-index: 1;
        }
        .forest-plot-ci {
            height: 2px;
            background-color: #007BFF;
            position: absolute;
            left: 0;
            top: 50%;
            transform: translateY(-50%);
        }
        .forest-plot-point {
            width: 12px;
            height: 12px;
            background-color: #007BFF;
            position: absolute;
            top: 50%;
            transform: translate(-50%, -50%);
            z-index: 2;
        }
        .text-shadow-custom {
            text-shadow: 2px 2px 8px rgba(0,0,0,0.7);
        }
    </style>
</head>
<body class="text-gray-200">

    <div class="container mx-auto p-4 md:p-8">

        <header class="text-center mb-12">
            <h1 class="text-4xl md:text-6xl font-black text-white text-shadow-custom leading-tight">THE ANATOMY OF A VERDICT</h1>
            <p class="text-xl md:text-2xl text-gray-300 mt-4 max-w-4xl mx-auto">A Visual Guide to Statistical Modeling in Clinical Trials for New Drug Efficacy</p>
        </header>

        <main class="space-y-12">
            
            <section id="foundation">
                <div class="text-center mb-8">
                    <h2 class="text-3xl font-bold text-white">The Foundation of Credible Analysis</h2>
                    <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">Robust statistical conclusions are not born from complex equations alone. They are built upon an unshakable foundation of rigorous clinical trial design. Without these core principles, any analysis is built on sand.</p>
                </div>
                <div class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-4 gap-8">
                    <div class="bg-gray-800 rounded-lg shadow-2xl p-6 text-center stat-card">
                        <div class="text-5xl mb-4">üé≤</div>
                        <h3 class="text-2xl font-bold mb-2">Randomization</h3>
                        <p class="text-gray-400">The cornerstone of eliminating bias. By randomly assigning participants, we create comparable groups, ensuring observed differences are likely due to the drug, not pre-existing factors.</p>
                    </div>
                    <div class="bg-gray-800 rounded-lg shadow-2xl p-6 text-center stat-card">
                        <div class="text-5xl mb-4">üé≠</div>
                        <h3 class="text-2xl font-bold mb-2">Blinding (Masking)</h3>
                        <p class="text-gray-400">Prevents knowledge of treatment assignments from influencing participant responses (placebo effect) or investigator assessments, ensuring objectivity.</p>
                    </div>
                    <div class="bg-gray-800 rounded-lg shadow-2xl p-6 text-center stat-card">
                        <div class="text-5xl mb-4">‚öñÔ∏è</div>
                        <h3 class="text-2xl font-bold mb-2">Control Groups</h3>
                        <p class="text-gray-400">The essential benchmark. Comparing the new drug to a placebo or standard of care allows us to distinguish its effects from natural disease progression or other external factors.</p>
                    </div>
                    <div class="bg-gray-800 rounded-lg shadow-2xl p-6 text-center stat-card">
                        <div class="text-5xl mb-4">üó≥Ô∏è</div>
                        <h3 class="text-2xl font-bold mb-2">Intent-to-Treat (ITT)</h3>
                        <p class="text-gray-400">"Analyze as randomized." This principle includes all participants in their original assigned groups, preserving the benefits of randomization and providing the least biased estimate of the treatment policy effect.</p>
                    </div>
                </div>
            </section>

            <section id="endpoints">
                <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6 md:p-8">
                    <div class="text-center mb-8">
                        <h2 class="text-3xl font-bold text-white">Defining Success: The Hierarchy of Endpoints</h2>
                        <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">The choice of endpoints dictates what a trial measures. A clear, pre-specified hierarchy is critical, especially when multiple outcomes are assessed, to prevent false-positive conclusions due to multiplicity.</p>
                    </div>
                    <div class="grid grid-cols-1 md:grid-cols-2 gap-8 items-start">
                        <div class="space-y-4">
                             <div class="bg-gray-800 rounded-lg p-4">
                                <h4 class="font-bold text-xl text-cyan-400">Primary Endpoints</h4>
                                <p class="text-gray-300">The most critical outcomes that form the basis for regulatory approval. The study's success hinges on these.</p>
                            </div>
                            <div class="bg-gray-800 rounded-lg p-4">
                                <h4 class="font-bold text-xl text-green-400">Secondary Endpoints</h4>
                                <p class="text-gray-300">Provide supportive evidence, demonstrate additional benefits, or explore other effects of the drug.</p>
                            </div>
                             <div class="bg-gray-800 rounded-lg p-4">
                                <h4 class="font-bold text-xl text-yellow-400">Exploratory Endpoints</h4>
                                <p class="text-gray-300">Used to generate new hypotheses for future research. Not used for formal efficacy claims.</p>
                            </div>
                        </div>
                        <div class="mt-8 md:mt-0">
                            <h3 class="text-2xl font-bold text-center mb-4 text-white">FDA View on Multiplicity</h3>
                            <div class="bg-gray-800 rounded-lg p-6">
                                <div class="relative">
                                    <div class="flex flex-col items-center">
                                        <div class="bg-gray-700 flow-node border-2 rounded-lg p-3 text-center w-full">
                                            <p class="font-bold">Multiple Primary Endpoints?</p>
                                        </div>
                                        <div class="h-8 flow-line"></div>
                                        <div class="flex w-full justify-around">
                                            <div class="w-2/5 text-center">
                                                <div class="bg-green-900/50 flow-node border-2 rounded-lg p-3">
                                                    <h5 class="font-semibold text-green-300">Co-Primary</h5>
                                                    <p class="text-sm text-gray-400">Success on ALL endpoints required. Multiplicity adjustment usually not needed.</p>
                                                </div>
                                            </div>
                                            <div class="w-2/5 text-center">
                                                <div class="bg-red-900/50 flow-node border-2 rounded-lg p-3">
                                                    <h5 class="font-semibold text-red-300">Multiple</h5>
                                                    <p class="text-sm text-gray-400">Success on ANY endpoint is sufficient. CRITICAL to pre-plan for Type I error control.</p>
                                                </div>
                                            </div>
                                        </div>
                                    </div>
                                </div>
                                <p class="text-center text-sm text-gray-500 mt-6">Failure to prospectively manage multiplicity can lead to rejection of efficacy claims by regulatory bodies like the FDA.</p>
                            </div>
                        </div>
                    </div>
                </div>
            </section>
            
            <section id="data-prep">
                 <div class="text-center mb-8">
                    <h2 class="text-3xl font-bold text-white">Forging the Data: The Pre-Analysis Gauntlet</h2>
                    <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">Raw data is rarely ready for analysis. It must be meticulously cleaned, and issues like missing values and outliers must be handled with principled, pre-specified strategies to avoid introducing bias.</p>
                </div>
                <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6 md:p-8">
                     <h3 class="text-2xl font-bold text-white text-center mb-6">Handling Missing Data: A Critical Choice</h3>
                     <div class="overflow-x-auto">
                        <table class="w-full text-left border-collapse">
                            <thead class="bg-gray-800">
                                <tr>
                                    <th class="p-3 font-bold uppercase text-gray-300 text-sm">Method</th>
                                    <th class="p-3 font-bold uppercase text-gray-300 text-sm">Assumption</th>
                                    <th class="p-3 font-bold uppercase text-gray-300 text-sm hidden md:table-cell">Risk of Bias</th>
                                    <th class="p-3 font-bold uppercase text-gray-300 text-sm">Regulatory View</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr class="bg-gray-700/50 border-b border-gray-600">
                                    <td class="p-3 font-semibold">LOCF</td>
                                    <td class="p-3">Condition is static after dropout</td>
                                    <td class="p-3 text-red-400 hidden md:table-cell">High</td>
                                    <td class="p-3 text-red-400 font-bold">‚ùå Highly Discouraged</td>
                                </tr>
                                 <tr class="bg-gray-700/50 border-b border-gray-600">
                                    <td class="p-3 font-semibold">Complete Case Analysis</td>
                                    <td class="p-3">Missing Completely at Random (MCAR)</td>
                                    <td class="p-3 text-red-400 hidden md:table-cell">High if not MCAR</td>
                                    <td class="p-3 text-yellow-400 font-bold">‚ö†Ô∏è Use with caution</td>
                                </tr>
                                <tr class="bg-gray-700/50 border-b border-gray-600">
                                    <td class="p-3 font-semibold">Multiple Imputation (MI)</td>
                                    <td class="p-3">Missing at Random (MAR)</td>
                                    <td class="p-3 text-green-400 hidden md:table-cell">Low</td>
                                    <td class="p-3 text-green-400 font-bold">‚úÖ Recommended</td>
                                </tr>
                                <tr class="bg-gray-700/50">
                                    <td class="p-3 font-semibold">Mixed Models (MMRM)</td>
                                    <td class="p-3">Missing at Random (MAR)</td>
                                    <td class="p-3 text-green-400 hidden md:table-cell">Low</td>
                                    <td class="p-3 text-green-400 font-bold">‚úÖ Recommended</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                    <p class="text-center text-sm text-gray-500 mt-4">The choice of method embodies fundamental assumptions. Using inappropriate methods like LOCF can introduce severe bias and undermine efficacy claims.</p>
                </div>
            </section>


            <section id="toolkit">
                <div class="text-center mb-8">
                    <h2 class="text-3xl font-bold text-white">The Analyst's Toolkit: Matching Models to Outcomes</h2>
                    <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">The type of primary endpoint directly dictates the statistical model used. Choosing the right model is essential for a valid analysis.</p>
                </div>
                <div class="grid grid-cols-1 lg:grid-cols-3 gap-8">
                    <div class="bg-gray-800/80 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-cyan-400 mb-4 text-center">Continuous Outcomes</h3>
                        <p class="text-gray-400 mb-6 text-center">e.g., Change in blood pressure, tumor size, or symptom scores.</p>
                        <div class="chart-container">
                            <canvas id="continuousChart"></canvas>
                        </div>
                        <div class="mt-6">
                            <h4 class="font-bold text-lg text-white">Common Model: ANCOVA/Linear Regression</h4>
                            <p class="text-gray-400 text-sm">Compares the mean outcome between groups while adjusting for baseline values. The goal is to determine if the drug causes a statistically significant change compared to the control.</p>
                        </div>
                    </div>

                    <div class="bg-gray-800/80 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-green-400 mb-4 text-center">Binary Outcomes</h3>
                        <p class="text-gray-400 mb-6 text-center">e.g., Clinical response (yes/no), adverse event occurrence.</p>
                        <div class="chart-container">
                            <canvas id="binaryChart"></canvas>
                        </div>
                        <div class="mt-6">
                            <h4 class="font-bold text-lg text-white">Common Model: Logistic Regression</h4>
                            <p class="text-gray-400 text-sm">Models the probability of a "success" event. It estimates the Odds Ratio (OR), indicating how the odds of the outcome change with the drug versus control.</p>
                        </div>
                    </div>

                    <div class="bg-gray-800/80 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-yellow-400 mb-4 text-center">Time-to-Event Outcomes</h3>
                        <p class="text-gray-400 mb-6 text-center">e.g., Time to disease progression, time to death (survival).</p>
                        <div class="chart-container">
                            <canvas id="timeToEventChart"></canvas>
                        </div>
                         <div class="mt-6">
                            <h4 class="font-bold text-lg text-white">Common Model: Cox Proportional Hazards</h4>
                            <p class="text-gray-400 text-sm">Compares the rate (hazard) of an event occurring over time. It estimates the Hazard Ratio (HR), indicating if the drug reduces or increases the event hazard.</p>
                        </div>
                    </div>
                </div>
            </section>
            
            <section id="evaluation">
                 <div class="text-center mb-8">
                    <h2 class="text-3xl font-bold text-white">The Verdict: Evaluating Model Performance</h2>
                    <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">A model's utility isn't just about its predictions, but how accurate and reliable those predictions are. We evaluate this through discrimination and calibration, and test its generalizability through validation.</p>
                </div>
                <div class="grid grid-cols-1 md:grid-cols-2 gap-8">
                    <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-white mb-4">Discrimination: Can the model separate groups?</h3>
                        <p class="text-gray-400 mb-4">Measured by the Area Under the ROC Curve (AUC). A value of 1.0 is perfect, while 0.5 is no better than chance. Good discrimination means the model can effectively rank individuals by their risk.</p>
                        <div class="chart-container">
                            <canvas id="rocChart"></canvas>
                        </div>
                    </div>
                     <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-white mb-4">Calibration: Are the predicted risks accurate?</h3>
                        <p class="text-gray-400 mb-4">Assessed with a calibration plot. A well-calibrated model's predictions align with observed outcomes (close to the diagonal line). Poor calibration can be misleading even with high AUC.</p>
                        <div class="chart-container">
                            <canvas id="calibrationChart"></canvas>
                        </div>
                    </div>
                </div>
            </section>
            
            <section id="interpretation">
                <div class="text-center mb-8">
                    <h2 class="text-3xl font-bold text-white">Beyond the P-value: Interpretation & Communication</h2>
                    <p class="mt-2 text-lg text-gray-400 max-w-3xl mx-auto">Results must be interpreted carefully. A "statistically significant" result is not always clinically important, and subgroup effects require rigorous testing, not just visual inspection.</p>
                </div>
                <div class="grid grid-cols-1 lg:grid-cols-2 gap-8">
                    <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-white mb-4">Statistical vs. Clinical Significance</h3>
                        <div class="flex items-center justify-around text-center">
                            <div>
                                <p class="text-4xl font-black text-cyan-400">p &lt; 0.05</p>
                                <p class="font-bold mt-2">Statistically Significant</p>
                                <p class="text-sm text-gray-400">The observed effect is unlikely due to random chance.</p>
                            </div>
                            <div class="text-4xl font-bold text-gray-500">‚â†</div>
                             <div>
                                <p class="text-4xl font-black text-green-400">Meaningful</p>
                                <p class="font-bold mt-2">Clinically Important</p>
                                <p class="text-sm text-gray-400">The effect is large enough to make a real difference to patients.</p>
                            </div>
                        </div>
                         <p class="mt-8 text-gray-400">A large trial can find a statistically significant but clinically trivial effect. Always consider the **effect size** and its **confidence interval**, not just the p-value.</p>
                    </div>
                    <div class="bg-gray-900/50 backdrop-blur-sm rounded-lg shadow-2xl p-6">
                        <h3 class="text-2xl font-bold text-white mb-4">Caution with Subgroups: The Forest Plot</h3>
                        <p class="text-gray-400 mb-6">Forest plots visualize effects across subgroups, but apparent differences can be misleading. The gold standard is a formal **test of interaction** to prove an effect truly differs between groups.</p>
                        <div class="space-y-4 text-sm">
                            <div class="flex items-center">
                                <span class="w-24 text-right mr-4 text-gray-400">Overall</span>
                                <div class="relative w-full h-6">
                                    <div class="forest-plot-line" style="height: 140%;"></div>
                                    <div class="forest-plot-ci" style="width: 30%; left: 10%;"></div>
                                    <div class="forest-plot-point" style="left: 25%;"></div>
                                </div>
                                <span class="w-24 ml-4 font-mono">0.65 [0.50, 0.82]</span>
                            </div>
                            <div class="flex items-center">
                                <span class="w-24 text-right mr-4 text-gray-400">Age < 65</span>
                                <div class="relative w-full h-6">
                                    <div class="forest-plot-ci" style="width: 40%; left: 5%;"></div>
                                    <div class="forest-plot-point" style="left: 25%;"></div>
                                </div>
                                <span class="w-24 ml-4 font-mono">0.62 [0.45, 0.85]</span>
                            </div>
                            <div class="flex items-center">
                                <span class="w-24 text-right mr-4 text-gray-400">Age ‚â• 65</span>
                                <div class="relative w-full h-6">
                                    <div class="forest-plot-ci" style="width: 50%; left: 20%;"></div>
                                    <div class="forest-plot-point" style="left: 45%;"></div>
                                </div>
                                <span class="w-24 ml-4 font-mono">0.80 [0.60, 1.10]</span>
                            </div>
                            <div class="flex items-center">
                                <span class="w-24 text-right mr-4 text-gray-400">Male</span>
                                <div class="relative w-full h-6">
                                    <div class="forest-plot-ci" style="width: 35%; left: 15%;"></div>
                                    <div class="forest-plot-point" style="left: 32.5%;"></div>
                                </div>
                                <span class="w-24 ml-4 font-mono">0.70 [0.55, 0.90]</span>
                            </div>
                            <div class="flex items-center">
                                <span class="w-24 text-right mr-4 text-gray-400">Female</span>
                                <div class="relative w-full h-6">
                                    <div class="forest-plot-ci" style="width: 45%; left: 8%;"></div>
                                    <div class="forest-plot-point" style="left: 30.5%;"></div>
                                </div>
                                <span class="w-24 ml-4 font-mono">0.68 [0.50, 0.88]</span>
                            </div>
                        </div>
                        <div class="flex justify-between text-xs mt-2 text-gray-500 px-4"><span>Favors Drug</span><span>Favors Control</span></div>
                    </div>
                </div>
            </section>
        </main>
        
        <footer class="text-center mt-16 text-gray-500 text-sm">
             <p>This infographic synthesizes key concepts from the comprehensive guide on statistical modeling for drug efficacy analysis.</p>
             <p>Data presented in charts is illustrative. All analysis of clinical trial data must be pre-specified and follow rigorous scientific and ethical standards.</p>
             <p class="mt-4">Infographic created on June 12, 2025.</p>
        </footer>

    </div>

<script>
    document.addEventListener('DOMContentLoaded', () => {

        const wrapLabel = (label, maxLength = 16) => {
            if (typeof label !== 'string' || label.length <= maxLength) {
                return label;
            }
            const words = label.split(' ');
            const lines = [];
            let currentLine = '';
            for (const word of words) {
                if ((currentLine + ' ' + word).trim().length > maxLength) {
                    lines.push(currentLine.trim());
                    currentLine = word;
                } else {
                    currentLine = (currentLine + ' ' + word).trim();
                }
            }
            if (currentLine) {
                lines.push(currentLine.trim());
            }
            return lines;
        };
        
        const tooltipTitleCallback = (tooltipItems) => {
            const item = tooltipItems[0];
            let label = item.chart.data.labels[item.dataIndex];
            if (Array.isArray(label)) {
              return label.join(' ');
            } else {
              return label;
            }
        };

        const vibrantPalette = {
            blue: '#007BFF',
            cyan: '#17A2B8',
            green: '#28A745',
            yellow: '#FFC107',
            red: '#DC3545',
            gray: '#6c757d'
        };

        const chartOptions = (extraOptions = {}) => ({
            responsive: true,
            maintainAspectRatio: false,
            plugins: {
                legend: {
                    labels: {
                        color: '#D1D5DB'
                    }
                },
                tooltip: {
                    callbacks: {
                        title: tooltipTitleCallback
                    }
                }
            },
            scales: {
                y: {
                    beginAtZero: true,
                    ticks: { color: '#9CA3AF' },
                    grid: { color: 'rgba(255, 255, 255, 0.1)' }
                },
                x: {
                    ticks: { color: '#9CA3AF' },
                    grid: { color: 'rgba(255, 255, 255, 0.1)' }
                }
            },
            ...extraOptions
        });

        new Chart(document.getElementById('continuousChart'), {
            type: 'bar',
            data: {
                labels: ['Placebo Group', 'New Drug Group'],
                datasets: [{
                    label: 'Mean Change in Biomarker (ng/mL)',
                    data: [ -5.2, -15.8],
                    backgroundColor: [vibrantPalette.gray, vibrantPalette.cyan],
                    borderColor: [vibrantPalette.gray, vibrantPalette.cyan],
                    borderWidth: 1
                }]
            },
            options: chartOptions({
                 scales: {
                    y: {
                        beginAtZero: false,
                        ticks: { color: '#9CA3AF' },
                        grid: { color: 'rgba(255, 255, 255, 0.1)' }
                    },
                    x: {
                        ticks: { color: '#9CA3AF' },
                        grid: { display: false }
                    }
                }
            })
        });

        new Chart(document.getElementById('binaryChart'), {
            type: 'doughnut',
            data: {
                labels: ['Responders', 'Non-Responders'],
                datasets: [{
                    label: 'Clinical Response Rate',
                    data: [65, 35],
                    backgroundColor: [vibrantPalette.green, vibrantPalette.gray],
                    borderColor: '#111827',
                    borderWidth: 4,
                    hoverOffset: 4
                }]
            },
            options: chartOptions({
                plugins: {
                    legend: {
                        position: 'top',
                         labels: {
                            color: '#D1D5DB'
                        }
                    },
                     tooltip: {
                        callbacks: {
                            title: (tooltipItems) => tooltipItems[0].label
                        }
                    }
                },
                scales: {
                    y: { display: false },
                    x: { display: false }
                }
            })
        });

        new Chart(document.getElementById('timeToEventChart'), {
            type: 'line',
            data: {
                labels: ['0', '6', '12', '18', '24', '30', '36'],
                datasets: [{
                    label: 'New Drug',
                    data: [1.0, 0.95, 0.92, 0.88, 0.85, 0.82, 0.80],
                    borderColor: vibrantPalette.yellow,
                    backgroundColor: 'rgba(255, 193, 7, 0.1)',
                    fill: true,
                    tension: 0.1
                }, {
                    label: 'Placebo',
                    data: [1.0, 0.90, 0.81, 0.70, 0.61, 0.55, 0.50],
                    borderColor: vibrantPalette.gray,
                    backgroundColor: 'rgba(108, 117, 125, 0.1)',
                    fill: true,
                    tension: 0.1
                }]
            },
            options: chartOptions({
                scales: {
                    y: {
                        min: 0,
                        max: 1,
                        title: { display: true, text: 'Survival Probability', color: '#D1D5DB'}
                    },
                    x: {
                        title: { display: true, text: 'Months', color: '#D1D5DB'}
                    }
                }
            })
        });
        
        new Chart(document.getElementById('rocChart'), {
            type: 'line',
            data: {
                labels: [0, 0.1, 0.2, 0.3, 0.4, 0.6, 1.0],
                datasets: [{
                    label: 'Model AUC: 0.85',
                    data: [0, 0.3, 0.65, 0.78, 0.88, 0.95, 1.0],
                    borderColor: vibrantPalette.blue,
                    backgroundColor: 'rgba(0, 123, 255, 0.1)',
                    fill: true,
                    tension: 0.4,
                    pointRadius: 0
                }, {
                    label: 'Chance',
                    data: [0, 0.1, 0.2, 0.3, 0.4, 0.6, 1.0],
                    borderColor: vibrantPalette.red,
                    borderDash: [5, 5],
                    fill: false,
                    pointRadius: 0
                }]
            },
            options: chartOptions({
                scales: {
                    y: {
                        min: 0,
                        max: 1,
                        title: { display: true, text: 'True Positive Rate (Sensitivity)', color: '#D1D5DB'}
                    },
                    x: {
                        min: 0,
                        max: 1,
                        title: { display: true, text: 'False Positive Rate (1 - Specificity)', color: '#D1D5DB'}
                    }
                }
            })
        });

        new Chart(document.getElementById('calibrationChart'), {
            type: 'scatter',
            data: {
                datasets: [{
                    label: 'Model Calibration',
                    data: [{x: 0.1, y: 0.08}, {x: 0.2, y: 0.22}, {x: 0.3, y: 0.31}, {x: 0.4, y: 0.38}, {x: 0.5, y: 0.52}, {x: 0.6, y: 0.59}, {x: 0.7, y: 0.73}, {x: 0.8, y: 0.78}, {x: 0.9, y: 0.91}],
                    backgroundColor: vibrantPalette.blue,
                    pointRadius: 5,
                    pointHoverRadius: 7
                }, {
                    type: 'line',
                    label: 'Perfect Calibration',
                    data: [{x: 0, y: 0}, {x: 1, y: 1}],
                    borderColor: vibrantPalette.red,
                    borderDash: [5, 5],
                    fill: false,
                    pointRadius: 0,
                    tension: 0.1
                }]
            },
            options: chartOptions({
                scales: {
                     y: {
                        min: 0,
                        max: 1,
                        title: { display: true, text: 'Observed Proportion', color: '#D1D5DB'}
                    },
                    x: {
                        min: 0,
                        max: 1,
                        title: { display: true, text: 'Predicted Probability', color: '#D1D5DB'}
                    }
                }
            })
        });
    });
</script>

</body>
</html>
